已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

The global burden of heterogeneity of lupus erythematosus interventional trials

医学 临床试验 随机对照试验 心理干预 干预(咨询) 内科学 精神科
作者
Jingru Tian,Hang Zhou,Dorthy Fang,Ping Yi,Pengpeng Cao,Juan Liu,Feng Xiong,Bo Zhang,Yi Liu,George C. Tsokos,Qianjin Lu
出处
期刊:Journal of Autoimmunity [Elsevier BV]
卷期号:128: 102798-102798 被引量:3
标识
DOI:10.1016/j.jaut.2022.102798
摘要

To explore bias in lupus erythematosus (LE) randomized clinical trials (RCTs) and to help the development of benchmarks for future trials and management. We searched systematically three databases and three registries to summarize the interventional randomized clinical trials (RCTs) and identify factors associated with participant loss. Trials which examined pharmacological interventions with control group were included and a meta-analysis was carried out by using fixed and random effects models to calculate risk ratio of participant loss in the intervention and control groups. A total of 481 trials with 68,582 participants met our inclusion criteria, organ specific interventional studies along with trials that address quality of life attributes and geopolitical disparities are missing or lagging behind. 90 trials were involved in the meta-analyses, the withdrawal ratio between intervention and control groups was distinctly influenced by national income of the trial-conducted country. In high income countries, the withdrawal ratio was relatively constant, while for trials conducted in low and middle income countries, the results were altered by trial registration, year of start, number of centers, number of participants, and primary outcome identification. Moreover, the comparability of participants was also worrying, trial location and registration status altered basal participant adherence. Our study reveals the unexpectedly huge heterogeneity brought by national income and trial registration in lupus RCTs worldwide. To maintain the fundamental repeatability and referenceability of LE RCTs, rigorously designed single-country trials with diverse inclusion criteria are needed.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
桐桐的应助被科研通管家采纳,获得10
2秒前
爆米花的应助被科研通管家采纳,获得10
3秒前
科研通AI2S的应助被科研通管家采纳,获得10
3秒前
pluto的应助被科研通管家采纳,获得10
3秒前
英俊的铭的应助被科研通管家采纳,获得10
3秒前
打打的应助被科研通管家采纳,获得10
3秒前
深情安青的应助被科研通管家采纳,获得10
3秒前
Maestro_S的应助被科研通管家采纳,获得10
3秒前
失物爱发布了新的文献求助10
3秒前
4秒前
泡泡完成签到 ,获得积分10
6秒前
7秒前
Jasper的应助被vesper采纳,获得10
10秒前
memo完成签到 ,获得积分10
10秒前
泠风来发布了新的文献求助10
11秒前
暮色晚钟完成签到,获得积分10
12秒前
叶素绿发布了新的文献求助10
12秒前
伍琬琦完成签到 ,获得积分10
13秒前
tangguaghui完成签到 ,获得积分20
14秒前
14秒前
咪咪完成签到,获得积分10
14秒前
Jazz33333333完成签到,获得积分10
15秒前
一个酒窝完成签到 ,获得积分10
16秒前
冷艳的紫发布了新的文献求助10
18秒前
QIU完成签到,获得积分10
19秒前
19秒前
tangguaghui关注了科研通微信公众号
20秒前
逮劳完成签到 ,获得积分10
22秒前
Maestro_S的应助被85Mwl采纳,获得10
22秒前
Nia完成签到,获得积分10
23秒前
丘比特的应助被失物爱采纳,获得10
23秒前
mqy完成签到 ,获得积分10
25秒前
淡定的幼南完成签到,获得积分10
26秒前
26秒前
9999完成签到 ,获得积分10
27秒前
炙热万声完成签到,获得积分10
27秒前
笙笙的应助被908328091采纳,获得10
29秒前
30秒前
棠真完成签到 ,获得积分10
31秒前
Beansprout完成签到,获得积分10
38秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172860
求助须知:如何正确求助?哪些是违规求助? 9565384
关于积分的说明 21779841
捐赠科研通 7764736
什么是DOI,文献DOI怎么找? 3431480
关于科研通互助平台的介绍 2555478
邀请新用户注册赠送积分活动 2476499